C-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells

Nature Immunology

Volumn 15, Issue 9, 2014, Pages 884-893

  Chou, Chun ^a   Pinto, Amelia K ^a   Curtis, Jonathan D ^a   Persaud, Stephen P ^a   Cella, Marina ^a   Lin, Chih Chung ^a   Edelson, Brian T ^a   Allen, Paul M ^a   Colonna, Marco ^a   Pearce, Erika L ^a   Diamond, Michael S ^a   Egawa, Takeshi ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AP4 PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 7; MYC PROTEIN; PROTEIN BCL 6; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; MYC PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP4, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SIZE; CHROMATIN IMMUNOPRECIPITATION; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; GLYCOLYSIS; HOST; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; WEST NILE FLAVIVIRUS; ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; WEST NILE FEVER;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; LYMPHOCYTE ACTIVATION; MICE; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION FACTORS; WEST NILE FEVER;

EID: 84906274052     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2943     Document Type: Article

References (50)

1. Kaech, S.M. & Wherry, E.J. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27, 393-405 (2007).
2. Zhang, N. & Bevan, M.J. CD8+ T cells: foot soldiers of the immune system. Immunity 35, 161-168 (2011).
3. Chang, C.H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239-1251 (2013).
4. Kaech, S.M. & Cui, W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12, 749-761 (2012).
5. MacIver, N.J., Michalek, R.D. & Rathmell, J.C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259-283 (2013).
6. van der Windt, G.J. & Pearce, E.L. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol. Rev. 249, 27-42 (2012).
7. Wang, R. & Green, D.R. Metabolic reprogramming and metabolic dependency in T cells. Immunol. Rev. 249, 14-26 (2012).
8. Kim, J. et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143, 313-324 (2010).
9. Nie, Z. et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151, 68-79 (2012).
10. Lin, C.Y. et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56-67 (2012).
11. Rahl, P.B. et al. c-Myc regulates transcriptional pause release. Cell 141, 432-445 (2010).
12. Sinclair, L.V. et al. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14, 500-508 (2013).
13. Wang, R. et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871-882 (2011).
14. Kaech, S.M. & Ahmed, R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2, 415-422 (2001).
15. Prlic, M., Hernandez-Hoyos, G. & Bevan, M.J. Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J. Exp. Med. 203, 2135-2143 (2006).
16. Blair, D.A. et al. Duration of antigen availability influences the expansion and memory differentiation of T cells. J. Immunol. 187, 2310-2321 (2011).
17. Porter, B.B. & Harty, J.T. The onset of CD8+-T-cell contraction is influenced by the peak of Listeria monocytogenes infection and antigen display. Infect. Immun. 74, 1528-1536 (2006).
18. Best, J.A. et al. Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation. Nat. Immunol. 14, 404-412 (2013).
19. Williams, M.A., Tyznik, A.J. & Bevan, M.J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 441, 890-893 (2006).
20. Obar, J.J. et al. CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses. Proc. Natl. Acad. Sci. USA 107, 193-198 (2010).
21. D'Souza, W.N. & Lefrancois, L. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J. Immunol. 171, 5727-5735 (2003).
22. Kalia, V. et al. Prolonged interleukin-2Rαexpression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32, 91-103 (2010).
23. Pipkin, M.E. et al. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32, 79-90 (2010).
24. Egawa, T. & Littman, D.R. Transcription factor AP4 modulates reversible and epigenetic silencing of the Cd4 gene. Proc. Natl. Acad. Sci. USA 108, 14873-14878 (2011).
25. Hu, Y.F., Luscher, B., Admon, A., Mermod, N. & Tjian, R. Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev. 4, 1741-1752 (1990).
26. Mermod, N., Williams, T.J. & Tjian, R. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 332, 557-561 (1988).
27. Pircher, H., Burki, K., Lang, R., Hengartner, H. & Zinkernagel, R.M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342, 559-561 (1989).
28. Maekawa, Y. et al. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat. Immunol. 9, 1140-1147 (2008).
29. Yoon, H., Kim, T.S. & Braciale, T.J. The cell cycle time of CD8+ T cells responding in vivo is controlled by the type of antigenic stimulus. PLoS ONE 5, e15423 (2010).
30. Petersen, L.R. & Fischer, M. Unpredictable and difficult to control-the adolescence of West Nile virus. N. Engl. J. Med. 367, 1281-1284 (2012).
31. Suthar, M.S., Diamond, M.S. & Gale, M. Jr. West Nile virus infection and immunity. Nat. Rev. Microbiol. 11, 115-128 (2013).
32. Shrestha, B. & Diamond, M.S. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 78, 8312-8321 (2004).
33. Wang, R. & Green, D.R. Metabolic checkpoints in activated T cells. Nat. Immunol. 13, 907-915 (2012).
34. Jung, P., Menssen, A., Mayr, D. & Hermeking, H. AP4 encodes a c-MYC-inducible repressor of p21. Proc. Natl. Acad. Sci. USA 105, 15046-15051 (2008).
35. Huang, C.Y.B.A.L., Walker, L.M., Bassing, C.H. & Sleckman, B.P. Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse. Eur. J. Immunol. 38, 342-349 (2008).
36. van der Windt, G.J. et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36, 68-78 (2012).
37. Lovén, J. et al. Revisiting global gene expression analysis. Cell 151, 476-482 (2012).
38. Chang, D.W., Claassen, G.F., Hann, S.R. & Cole, M.D. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol. Cell. Biol. 20, 4309-4319 (2000).
39. Yeh, E. et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 6, 308-318 (2004).
40. de Alboran, I.M. et al. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14, 45-55 (2001).
41. Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661-665 (2007).
42. Zehn, D., Lee, S.Y. & Bevan, M.J. Complete but curtailed T-cell response to very low-affinity antigen. Nature 458, 211-214 (2009).
43. Hogquist, K.A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994).
44. Mombaerts, P. et al. Mutations in T-cell antigen receptor genes αand βblock thymocyte development at different stages. Nature 360, 225-231 (1992).
45. Willerford, D.M. et al. Interleukin-2 receptor αchain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530 (1995).
46. Morita, S., Kojima, T. & Kitamura, T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063-1066 (2000).
47. Bolstad, B.M., Irizarry, R.A., Astrand, M. & Speed, T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193 (2003).
48. Ciofani, M. et al. A validated regulatory network for Th17 cell specification. Cell 151, 289-303 (2012).
49. Langmead, B. & Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359 (2012).
50. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).